IDDF2021-ABS-0036 Prognostic Value of the CEA, RDW-CV, RDW-SD Combined with CIP2A in the Serum of Patients with Colorectal Cancer

Wei Chen,Xiang Peng
DOI: https://doi.org/10.1136/gutjnl-2021-iddf.114
2021-01-01
Abstract:Background To investigate the prognostic value of CEA, RDW-CV, RDW-SD and CIP2A in the serum of colorectal cancer (CRC) patients after resection. Methods The clinical and follow-up data of 61 CRC patients who underwent surgery in the sixth Affiliated Hospital of Sun Yat-sen University January 2012 and December. The association between the CIP2A, CEA, RDW-CV, RDW-SD and the prognosis was evaluated. The Kaplan-Meier curves were used to identify the overall survival (OS) rates of the different groups. Results At the end of the follow-up period (2020), the median follow-up is 207 months (range, 17-260 months). The 5-year OS of patients with low level of serum CIP2A was not better than that of high level, which is contrary to other indicators (CEA, RDW-CV and RDW-SD). Cox multivariate analysis showed that the age, N stage and M stage were independent factors influencing patient survival. The CRRC (combination of CEA, RDW-CV, RDW-SD and CIP2A) has better prognostic power than other indicators (CIP2A, CEA, RDW-CV and RDW-SD) according to the receiver operating characteristic (ROC) curve analysis. Conclusions CRRC could be used as a better prognostic biomarker for CRC than the CEA, RDW-CV, RDW-SD and CIP2A alone.
What problem does this paper attempt to address?